• Geographic Atrophy
  • Uveitis
  • Ophthalmology
  • Retinal Surgery
  • Imaging
  • AMD
  • Diabetic Macular Edema
  • Diabetic Retinopathy

Latest News

Image Credit: ©SeanPavonePhoto - stock.adobe.com
Ocular Therapeutix to present 12-month top-line data from Phase 1 OTX-TKI trial for wet AMD at the 2023 Clinical Trials at the Summit Annual Meeting

June 6th 2023

Ocular Therapeutix is scheduled to present trial results as well as participate in a panel discussion and sponsor a presentation at the 2023 Clinical Trials at the Summit Annual Meeting.

Image Credit: ©luchschenF - stock.adobe.com
Enrollment complete for EyePoint’s phase 2 PAVIA trial of EYP-1901 in non-proliferative diabetic retinopathy

June 5th 2023

Image Credit: ©cherdchai - stock.adobe.com
Alkeus announces $150 Million Series B Financing to support gildeuretinol (ALK-001) and the appointment of Joshua Boger to executive chairman

June 5th 2023

Image Credit: ©Fox_Design - stock.adobe.com
IRIS completes 1 million diabetic retinal exams

June 3rd 2023

Image Credit: ©desertsands - stock.adobe.com
First Patient receives dosing with AVD-104 in the Phase 2 SIGLEC trial for the treatment of Geographic Atrophy

June 2nd 2023

Latest Videos

Latest News

© 2023 MJH Life Sciences

All rights reserved.